For more than a decade, insurance companies and physician groups have been locked in a high-stakes fight over one pivotal question in Florida law: Can doctors step into the role of pharmacists and dispense medications to injured workers—often at significantly higher prices?
This week, a Florida appeals court may have delivered the long-awaited final word—handing employers and insurance carriers a multimillion-dollar victory after years of fighting to roll back workers’ compensation rules that permitted physician dispensing.
"This is huge. It’s not often you see a complete vindication like this," said Jerry Fogel, a consultant with Imagine Clinical who has been at the forefront of the physician-dispensing battle for years.
On Wednesday, the Florida 1st District Court of Appeal overturned a ruling by the Florida Division of Administrative Hearings that had upheld a 2023 regulation from the Florida Division of Workers' Compensation. First proposed in 2020, that rule marked a sharp departure from years of regulatory interpretation—asserting that Florida law does not allow insurers to deny reimbursement when physicians dispense medications to injured workers.
The 2023 rule has now been struck down. What happens next remains uncertain: the appellees—including the Florida Department of Financial Services, the Florida Medical Association, and Prescription Partners LLC—must decide whether to take the fight to the Florida Supreme Court or return to the drawing board and rewrite the rule altogether.
Representatives for those organizations and their attorneys could not be reached for comment Thursday. But behind the scenes, speculation spread quickly that a new push to rewrite the law may already be in motion—just days before the Florida legislative session is scheduled to adjourn on March 13.
Where injured workers fill their prescriptions may not sound like a headline issue. After all, workers’ compensation rates for most employers have dropped sharply in Florida and across the country over the past two decades.
But insurers in the case argue the stakes are far higher than they appear. They contend that medical costs could fall—and patient outcomes could improve—if physicians stepped away from the business of selling the very medications they prescribe. The concern, they say, is a built-in conflict of interest. Unlike pharmacists, doctors are not always trained across the full spectrum of medications, drug interactions, and pricing structures—raising questions about both cost and care.
Ending physician dispensing could save workers’ compensation insurers up to $43 million over the next five years, according to an amicus brief filed with the appeals court by the Florida Insurance Council and the American Property Casualty Insurance Association.
In their filing, the groups argued that curbing the practice wouldn’t just trim costs—it could reshape the financial landscape of Florida’s workers’ comp system.
The groups cited research from the Workers’ Compensation Research Institute showing that medications often cost significantly more when physicians dispense and bill for them directly. For example, the pain reliever Vicodin averages $1.41 per pill in a doctor’s office—compared with just 52 cents at a pharmacy. The anti-inflammatory drug Mobic can run as high as $5.86 per pill when physician-dispensed, versus $3.19 at a pharmacy, the brief states.
The price gap, they argue, is more than marginal—it’s systemic.
“This increase would need to be factored into the cost of workers’ compensation insurance, unraveling years of legislative reform,” attorneys Maria Elena Abate and Michael Billmeier Jr. wrote in the brief.
The Florida Insurance Council quickly applauded the court’s decision, calling it a decisive victory for employers and a turning point in the long-running fight over physician dispensing.
“We believe this decision reinforces an important safeguard against misaligned financial incentives in physician dispensing, protecting injured workers and helping prevent unnecessary cost increases that impact Florida employers,” said George Feijoo, of Floridian Partners, representing the Council
Supporters of physician dispensing have long argued that the practice benefits injured workers—saving them time, eliminating extra trips to the pharmacy, and getting medication into their hands faster to speed recovery.
In its response brief, attorneys for Prescription Partners LLC went a step further, suggesting the entire controversy may have been misplaced. Under Florida law, they noted, workers’ compensation insurers typically select the treating physician in most claims—meaning carriers already control the front end of the process.
“A carrier has the choice to send the injured worker to any provider of the carrier’s choice, including a provider who is not a dispensing practitioner, and thereby avoid any practitioner-dispensing of medications at all,” attorneys Virginia Dailey and Lindsay Ervin wrote.
But Jerry Fogel countered that in today’s profit-driven healthcare landscape—where major private equity firms hold stakes in many provider practices—walking away from physician dispensing isn’t a simple choice. Even the promise of higher reimbursement rates and a steadier flow of patients may not be enough to offset the financial pressures shaping modern medical practices.
“That worked great 20 years ago,” Fogel said. “But nowadays, no one owns their own operation anymore. The medical people don’t make the decisions so much.”
The appeals court acknowledged that Florida’s statutes on physician dispensing are anything but crystal clear. In some provisions, the law plainly distinguishes physicians from pharmacists, signaling they are not one and the same. Yet elsewhere, the statute lays out a pricing formula specifically for medications sold by doctors—capping reimbursement at the average wholesale price plus a $4.18 dispensing fee. For repackaged drugs, the cap rises to 112.5% of the wholesale price, along with an $8 fee.
The mixed signals, the court suggested, have fueled years of confusion—and litigation.
But Jerry Fogel argued that price caps alone don’t eliminate the underlying incentive. When physicians both prescribe and dispense, he said, they still have a financial stake in writing more prescriptions—and in choosing higher-priced medications—potentially driving up costs for insurers and employers alike.
Insurance groups say physician dispensing has evolved into a highly profitable revenue stream for many medical practices. Among the most prominent players is Prescription Partners LLC, headquartered in Hollywood. The company provides the software, packaging, and billing infrastructure that enables doctors to operate in-office pharmacies and fold prescription drugs directly into their charges.
Industry leaders on the insurance side argue that the firm has been a central force behind Florida’s regulatory efforts to preserve and expand physician dispensing—turning what began as a convenience for patients into a major policy battleground.
Paul Zimmerman, a physician, is listed as CEO of Prescription Partners LLC. He could not be reached for comment Thursday.
In a past interview with NBC News, however, Zimmerman pushed back on insurers’ claims, arguing that carriers have skewed the debate by spotlighting only a handful of higher-priced medications while ignoring the broader pricing picture.
On the opposite side of the fight stood Publix Super Markets, one of Florida’s largest employers and the lead appellant in the case. The company had a dual stake in the outcome: controlling its own workers’ compensation costs and protecting its extensive pharmacy business, which could see a boost in prescription volume now that insurers may deny reimbursement when physicians dispense medications to injured workers.
Other appellants included several Florida workers’ compensation insurers, led by Normandy Insurance Company, based in Deerfield Beach. Jerry Fogel credited Normandy with underwriting and sustaining much of the litigation—pressing forward even after other carriers stepped away.
They were joined in the appeal by Zenith Insurance Company, headquartered in Sarasota; Bridgefield Employers Insurance Company; BusinessFirst Insurance Company; and RetailFirst Insurance Company—a coalition that turned a regulatory dispute into a defining courtroom showdown.
Photo | Creator: supattra suparit | Credit: PHOTO4U - stock.adobe.com
